On the prevalence of the PAX8-PPARG fusion resulting from the chromosomal translocation t(2;3)(q13;p25) in adenomas of the thyroid

Cancer Genetics

Volumn 204, Issue 6, 2011, Pages 334-339

  Klemke, Markus ^a   Drieschner, Norbert ^a   Laabs, Anne ^a   Rippe, Volkhard ^a   Belge, Gazanfer ^a   Bullerdiek, Jörn ^a,b   Sendt, Wolfgang ^c  

^a UNIVERSITY OF BREMEN   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c St Joseph Stift Hospital Bremen   (Germany)

Author keywords

Follicular thyroid neoplasia; HMGA2; PAX8 PPARG fusion; T(2; 3)(q13; p25)

Indexed keywords

MESSENGER RNA; ONCOPROTEIN; PAX8 PPARGAMMA FUSION PROTEIN, HUMAN; PAX8-PPARGAMMA FUSION PROTEIN, HUMAN;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 3; CYTOGENETICS; FEMALE; FUSION GENE; GENE; HISTOPATHOLOGY; HMGA2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; PAX8 GENE; PPARG GENE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID ADENOMA; THYROID FOLLICULAR ADENOMA; ADENOCARCINOMA; CHROMOSOME 2; CHROMOSOME 3; GENETICS; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; THYROID TUMOR; TUMOR CELL CULTURE;

ADENOCARCINOMA, FOLLICULAR; BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 3; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 80052858553     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2011.05.001     Document Type: Article

References (33)

1. Schmid K.W., Farid N.R. How to define follicular thyroid carcinoma?. Virchows Arch 2006, 448:385-393.
2. Teyssier J.R., Liautaud-Roger F., Ferre D., et al. Chromosomal changes in thyroid tumors. Relation with DNA content, karyotypic features, and clinical data. Cancer Genet Cytogenet 1990, 50:249-263.
3. Sozzi G., Miozzo M., Cariani T.C., et al. A t(2;3)(q12-13;p24-25) in follicular thyroid adenomas. Cancer Genet Cytogenet 1992, 64:38-41.
4. Roque L., Castedo S., Gomes P., et al. Cytogenetic findings in 18 follicular thyroid adenomas. Cancer Genet Cytogenet 1993, 67:1-6.
5. Kroll T.G., Sarraf P., Pecciarini L., et al. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma. Science 2000, 289:1357-1360.
6. Belge G., Meyer A., Klemke M., et al. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. Genes Chromosomes Cancer 2008, 47:56-63.
7. Chiappetta G., Ferraro A., Vuttariello E., et al. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias. Eur J Cancer 2008, 44:1015-1021.
8. Prasad N.B., Somervell H., Tufano R.P., et al. Identification of genes differentially expressed in benign versus malignant thyroid tumors. Clin Cancer Res 2008, 14:3327-3337.
9. Lappinga P.J., Kip N.S., Jin L., et al. HMGA2 gene expression analysis performed on cytologic smears to distinguish benign from malignant thyroid nodules. Cancer Cytopathol 2010, 118:287-297.
10. ISCN 2009: An International System for Human Cytogenetic Nomenclature 2009, Karger, Basel. L.G. Schaffer, M.L. Slovak, L.J. Campbell (Eds.).
11. Castagné C., Muhlematter D., Beyer V., et al. Determination of cutoff values to detect small aneuploid clones by interphase fluorescence in situ hybridization: the Poisson model is a more appropriate approach. Should single-cell trisomy 8 be considered a clonal defect?. Cancer Genet Cytogenet 2003, 147:99-109.
12. Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer (2011). Mitelman F, Johansson B, Mertens F, editors. Available at: Accessed on February 25, 2011. http://www.cgap.nci.nih.gov/Chromosomes/Mitelman.
13. Antonini P., Vénuat A.M., Linares G., et al. Cytogenetic abnormalities in thyroid adenomas. Cancer Genet Cytogenet 1991, 52:157-164.
14. Belge G., Roque L., Soares J., et al. Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet 1998, 101:42-48.
15. Roque L., Rodrigues R., Pinto A., et al. Chromosome imbalances in thyroid follicular neoplasms: a comparison between follicular adenomas and carcinomas. Genes Chromosomes Cancer 2003, 36:292-302.
16. French C.A., Alexander E.K., Cibas E.S., et al. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol 2003, 162:1053-1060.
17. Castro P., Rebocho A.P., Soares R.J., et al. PAX8-PPARγ rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 2006, 91:213-220.
18. Chia W.K., Sharifah N.A., Reena R.M., et al. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms. Cancer Genet Cytogenet 2010, 196:7-13.
19. Cheung L., Messina M., Gill A., et al. Detection of the PAX8-PPARγ fusion oncogene in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 2003, 88:354-357.
20. Algeciras-Schimnich A., Milosevic D., McIver B., et al. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis. Clin Chem 2010, 56:391-398.
21. Nikiforova M.N., Biddinger P.W., Caudill C.M., et al. PAX8-PPARγ rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol 2002, 26:1016-1023.
22. Marques A.R., Espadinha C., Catarino A.L., et al. Expression of PAX8-PPARγ1 rearrangements in both follicular thyroid carcinomas and adenomas. J Clin Endocrinol Metab 2002, 87:3947-3952.
23. Martelli M.L., Iuliano R., Le Pera I., et al. Inhibitory effects of peroxisome poliferator-activated receptor γ on thyroid carcinoma cell growth. J Clin Endocrinol Metab 2002, 87:4728-4735.
24. Aldred M.A., Morrison C., Gimm O., et al. Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas. Oncogene 2003, 22:3412-3416.
25. Nikiforova M.N., Lynch R.A., Biddinger P.W., et al. RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 2003, 88:2318-2326.
26. Dwight T., Thoppe S.R., Foukakis T., et al. Involvement of the PAX8/peroxisome proliferator-activated receptor γ rearrangement in follicular thyroid tumors. J Clin Endocrinol Metab 2003, 88:4440-4445.
27. Hibi Y., Nagaya T., Kambe F., et al. Is thyroid follicular cancer in Japanese caused by a specific t(2;3)(q13;p25) translocation generating Pax8-PPARγ fusion mRNA?. Endocr J 2004, 51:361-366.
28. Lacroix L., Mian C., Barrier T., et al. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues. Eur J Endocrinol 2004, 151:367-374.
29. Nakabashi C.C., Guimarães G.S., Michaluart P., et al. The expression of PAX8-PPARγ rearrangements is not specific to follicular thyroid carcinoma. Clin Endocrinol (Oxf) 2004, 61:280-282.
30. Sahin M., Allard B.L., Yates M., et al. PPARγ staining as a surrogate for PAX8/PPARγ fusion oncogene expression in follicular neoplasms: clinicopathological correlation and histopathological diagnostic value. J Clin Endocrinol Metab 2005, 90:463-468.
31. Giordano T.J., Au A.Y., Kuick R., et al. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation. Clin Cancer Res 2006, 12:1983-1993.
32. Di Cristofaro J., Silvy M., Lanteaume A., et al. Expression of tpo mRNA in thyroid tumors: quantitative PCR analysis and correlation with alterations of ret, Braf, ras and pax8 genes. Endocr Relat Cancer 2006, 13:485-495.
33. Banito A., Pinto A.E., Espadinha C., et al. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours. Clin Endocrinol (Oxf) 2007, 67:706-711.